FDA’s Shuren Grilled About Handling Of MDUFA V At House Hearing

 
• By Elizabeth Orr
  
CDRH director Jeff Shuren testifies in the US House of Representatives on 30 March 2022.
CDRH director Jeff Shuren testifies before the US House of Representatives health subcommittee on 30 March. • Source: YouTube/Informa
Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

SpotifyApple PodcastsWebsite

More from Regulation

More from Policy & Regulation